Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behcet's disease

被引:20
作者
Yücel, AE
Kart-Köseoglu, H
Akova, YA
Demirhan, B
Boyacioglu, S
机构
[1] Baskent Univ, Dept Rheumatol, TR-06490 Ankara, Turkey
[2] Baskent Univ, Dept Ophthalmol, TR-06490 Ankara, Turkey
[3] Baskent Univ, Dept Pathol, TR-06490 Ankara, Turkey
[4] Baskent Univ, Dept Gastroenterol, TR-06490 Ankara, Turkey
关键词
D O I
10.1093/rheumatology/keh056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:394 / 396
页数:4
相关论文
共 10 条
[1]   Thalidomide: Current and potential clinical applications [J].
Calabrese, L ;
Fleischer, AB .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (06) :487-495
[2]  
Chang Hyun Kyu, 2001, Korean Journal of Internal Medicine, V16, P47
[3]   Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial [J].
Hamuryudan, V ;
Mat, C ;
Saip, S ;
Ozyazgan, Y ;
Siva, A ;
Yurdakul, S ;
Zwingenberger, K ;
Yazici, H .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :443-+
[4]   Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet's disease: A case report [J].
Hassard, PV ;
Binder, SW ;
Nelson, V ;
Vasiliauskas, EA .
GASTROENTEROLOGY, 2001, 120 (04) :995-999
[5]   Behcet's ileocolitis: Successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy - Report of a case [J].
Kram, MT ;
May, LD ;
Goodman, S ;
Molinas, S .
DISEASES OF THE COLON & RECTUM, 2003, 46 (01) :118-121
[6]  
Mussack T, 2003, AM J GASTROENTEROL, V98, P703
[7]  
Raziuddin S, 1998, J RHEUMATOL, V25, P329
[8]  
Sayinalp N, 1996, J RHEUMATOL, V23, P321
[9]   Behcet's disease: a new target for anti-tumour necrosis factor treatment [J].
Sfikakis, PP .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 :51-53
[10]   Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor α antibody [J].
Travis, SPL ;
Czajkowski, M ;
McGovern, DPB ;
Watson, RGP ;
Bell, AL .
GUT, 2001, 49 (05) :725-728